Medivir´s phase II study of MIV-711 in patients with osteoarthritis published in Annals of Internal Medicine

Read more

Investigator-initiated phase II clinical study of remetinostat started in patients with squamous cell carcinoma

Read more

Futility analysis performed of the phase II combination study with birinapant and Keytruda® in colorectal cancer patients

Read more

Partner with Medivir

Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.